Providing market intelligence for more than 35 years

In The News

Technology Stock Roundup: Tech Stocks Down But MSFT/INTC Gain

Google Pulls Ahead of Apple in TV Streaming: According to a report from research firm Parks Associates, Google’s Chromecast now accounts for 20% of sales from set-top-box/streaming sticks. Roku remains in the lead with a 29% share, but Apple has been pushed to third place with a 17% share. Amazon’s Fire TV is at number four with 10%. Chromecast is the cheapest device at $35, Roku has two devices at $50 and $99, while both Apple TV and Fire TV come for $90.

The price differential is on account of additional hardware that the other devices provide so you won’t need a separate device to watch content/run apps, but that’s less important right now as it is fetching Google market share. And additional devices can always follow.  

From the article "Technology Stock Roundup: Tech Stocks Down But MSFT/INTC Gain" by Sejuti Banerjea.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...